ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Selling, general and administrative (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $13.9B | +16.7% | 4.9% | 6.2% |
| Selling, general and administrative (TTM) | $13.9B |
|---|---|
| YoY | +16.7% |
| 5-year CAGR | 4.9% |
| 10-year CAGR | 6.2% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $12.3B | +5.4% |
| 2024 | $11.7B | +6.8% |
| 2023 | $10.9B | −2.7% |
| 2022 | $11.2B | −0.7% |
| 2021 | $11.3B | +16.8% |
| 2020 | $9.7B | −0.7% |
| 2019 | $9.8B | +0.2% |
| 2018 | $9.7B | +6.1% |
| 2017 | $9.2B | +36.3% |
| 2016 | $6.7B | −0.7% |
| 2015 | $6.8B | +3.9% |
| 2014 | $6.5B | +2.5% |
| 2013 | $6.4B | −5.4% |
| 2012 | $6.7B | −8.6% |
| 2011 | $7.4B | −29.0% |
| 2010 | $10.4B | +23.4% |
| 2009 | $8.4B | −0.4% |
| 2008 | $8.4B | +13.9% |
| 2007 | $7.4B | — |